What is the expected growth forecast for the Legal Marijuana for Medical Use market?

The market is expected to grow at a CAGR of 15.3% from 2023 to 2028.

What are the key drivers of the Legal Marijuana for Medical Use market?

Increasing demand and government support are key drivers of the market.

What are the challenges facing the Legal Marijuana for Medical Use market?

Regulatory issues and social stigma are significant challenges facing the market.

Which regions are leaders in the Legal Marijuana for Medical Use market?

North America and Europe are the leading regions in the market.

Who are the top companies in the Legal Marijuana for Medical Use market?

Top companies include Canopy Growth and Aurora Cannabis.

What are the future opportunities in the Legal Marijuana for Medical Use market?

Emerging markets and new products offer future opportunities for growth.

How is technology impacting the Legal Marijuana for Medical Use market?

Technology is improving production efficiency and product quality.

What is the current regulatory landscape for the Legal Marijuana for Medical Use market?

The regulatory landscape is evolving with increasing government support.

What is the future outlook for the Legal Marijuana for Medical Use market?

The future outlook is positive with increasing demand and growth.

Legal Marijuana for Medical Use Market Growing at CAGR — 2026 Report

Legal Marijuana for Medical Use by Application (Cancer, Arthritis, Migraine, Epilepsy, Others), by Types (THC-dominant, CBD-dominant, Balanced THC & CBD), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $24000 million

CAGR: 15.1%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $24000 million

CAGR: 15.1%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Legal Marijuana for Medical Use Market Size | CAGR 15.1 Forecast 2033

Legal Marijuana for Medical Use Market Growing at CAGR — 2026 Report

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $24000 million

CAGR: 15.1%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $24000 million

CAGR: 15.1%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Legal Marijuana for Medical Use Market Overview

The Legal Marijuana for Medical Use market refers to the industry involved in the cultivation, processing, and distribution of marijuana for medical purposes. As the Legal Marijuana for Medical Use market size continues to grow, it is essential to understand the growth outlook, market forecast, and industry expansion. The scope of this market encompasses various segments, including medical marijuana, cannabis, and therapeutic marijuana, which are driving the industry's growth. The current Legal Marijuana for Medical Use market size is approximately $22.5 billion, and it is expected to witness a significant growth forecast with a compound annual growth rate (CAGR) of 15.3% during the forecast period from 2026 to 2033. The macro drivers of this market include the increasing demand for medical marijuana, advancements in technology shifts, and changing regulations.

Loading chart…

The key forces shaping the industry include the increasing adoption of medical marijuana among patients, advancements in cannabis research, and the rising competitive intensity among market players. The largest region in the Legal Marijuana for Medical Use market is North America, while the fastest-growing region is expected to be Asia-Pacific. The growth outlook of this market is promising, driven by the increasing demand for therapeutic marijuana and the expanding supply-chain dynamics. As the industry continues to evolve, it is essential for C-suite, strategic planners, and BD teams to stay informed about the latest trends and developments in the Legal Marijuana for Medical Use market.

Report Overview

Report Attribute	Details
Market size value in 2025	24.00 billion
Revenue forecast in 2033	73.93 billion
Growth rate	CAGR of 15.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Canopy Growth Corporation; GW Pharmaceuticals, plc; Aurora Cannabis, Inc.; Aphria, Inc.; MedReleaf Corporation; Insys Therapeutics, Inc.; CanniMed Therapeutics, Inc.; Cara Therapeutics, Inc.; United Cannabis Corporation; Medicine Man; mCig Inc
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Legal Marijuana for Medical Use market is poised for significant growth, driven by shifting regulatory landscapes and increasing demand for alternative therapies. As the market continues to evolve, understanding the underlying dynamics is crucial for stakeholders to navigate this complex and rapidly changing industry.

Growth Drivers2 items

Rising awareness about the therapeutic benefits of marijuana, coupled with advancements in cannabis research, is expected to fuel the growth of the Legal Marijuana for Medical Use market size. This, in turn, will contribute to an upward growth forecast.

Government support and deregulation in various countries are providing a conducive environment for the Legal Marijuana for Medical Use market to flourish, with many states and nations legalizing marijuana for medical purposes.

Restraints2 items

Stringent regulatory requirements and the high cost associated with obtaining licenses to cultivate and distribute medical marijuana are significant restraints on the growth of the Legal Marijuana for Medical Use market.

Social stigma and lack of standardization in dosing and potency of marijuana products are also hindering the growth forecast of the Legal Marijuana for Medical Use market, making it challenging for companies to operate effectively.

Opportunities2 items

Increasing investment in cannabis research and development is creating new opportunities for the Legal Marijuana for Medical Use market, enabling companies to develop more effective and targeted treatments. This is expected to drive market growth and expansion.

The growing demand for medical marijuana in emerging economies presents a significant opportunity for companies to expand their operations and increase their market share in the Legal Marijuana for Medical Use market.

Challenges2 items

Ensuring the quality and safety of marijuana products while maintaining compliance with varying regulatory requirements across different regions is a major challenge facing the Legal Marijuana for Medical Use market. This complexity can hinder market growth and player participation.

Managing the supply chain effectively to meet the increasing demand for medical marijuana while keeping costs under control is another significant challenge that companies in the Legal Marijuana for Medical Use market must address to achieve a favorable growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Legal Marijuana for Medical Use market refers to the various therapeutic uses of marijuana for treating different medical conditions. This segment is crucial in understanding the Legal Marijuana for Medical Use segmentation and its contribution to the overall market size. The application segment includes subtypes such as pain management, seizures and epilepsy, and multiple sclerosis, among others. Each subtype has a significant impact on the market size, with some applications being more prevalent than others.

The Types segment of the Legal Marijuana for Medical Use market categorizes the different forms of marijuana used for medical purposes. This segment is vital in market taxonomy as it helps in identifying the various products available in the market and their respective market shares. The types segment includes subtypes such as dried marijuana, marijuana extracts, and marijuana-infused products. Understanding the types segment is essential in analyzing the overall market size and trends in the Legal Marijuana for Medical Use market.

Legal Marijuana for Medical Use Segmentation Breakdown10 items

Application

Cancer

Arthritis

Migraine

Epilepsy

Others

Types

THC-dominant

CBD-dominant

Balanced THC & CBD

Regional Insights

Loading chart…

The Legal Marijuana for Medical Use market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption and investments in the medical cannabis industry. Key drivers for North America include favorable policies, a mature ecosystem, and growing demographics of patients seeking alternative treatments.

In Europe, key drivers include infrastructure development, regulatory frameworks, and rising demand for medical cannabis products. Asia Pacific's growth is fueled by government support, research initiatives, and a large patient population. Latin America's market is driven by expanding distribution channels, partnerships, and increasing awareness about medical cannabis benefits. The Middle East & Africa region is expected to experience growth due to growing investments, trade agreements, and a rising patient base.

The regional forecast indicates a positive outlook for the Legal Marijuana for Medical Use market, with each region presenting unique opportunities and challenges. As the market continues to evolve, it is essential to monitor regulatory developments, market trends, and competitive landscapes to capitalize on emerging opportunities and drive business growth.

Competitive Landscape

The Legal Marijuana for Medical Use market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers in this market include pricing, distribution, product innovation, certifications, and regulatory approvals. The Legal Marijuana for Medical Use competitive landscape is characterized by high competition, with companies focusing on differentiation through quality, branding, and customer service.

Common strategies among market players include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting to these challenges by focusing on specific strategic initiatives, including:

Key Legal Marijuana for Medical Use Companies11 items

Canopy Growth Corporation

GW Pharmaceuticals, plc

Aurora Cannabis, Inc.

Aphria, Inc.

MedReleaf Corporation

Insys Therapeutics, Inc.

CanniMed Therapeutics, Inc.

Cara Therapeutics, Inc.

United Cannabis Corporation

Medicine Man

mCig Inc

Market Ecosystem

The Legal Marijuana for Medical Use ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the cultivation, processing, and distribution of medical marijuana products. The ecosystem involves a complex interplay of participants, each contributing to the production and delivery of medical marijuana products to end users.

Raw material suppliers — provide cannabis seeds and plants

OEMs/manufacturers — produce medical marijuana products

Technology providers — offer cultivation and processing equipment

Distributors/channel partners — supply products to dispensaries

Regulators/standards bodies — oversee licensing and compliance

Service providers/after-sales — provide patient support and education

End users/buyers — purchase medical marijuana products for treatment

In the Legal Marijuana for Medical Use ecosystem, control points are largely influenced by regulators and standards bodies, who enforce strict licensing and compliance requirements. Dependency risks arise from input constraints, such as limited access to high-quality cannabis seeds, and standards approvals, which can impact product availability. Switching costs and partnerships are also significant, as companies may need to adapt to changing regulations or form alliances to ensure interoperability. A thorough value chain analysis is essential to understanding these dynamics and navigating the ecosystem's complexities.

Recent Industry Insights

The Legal Marijuana for Medical Use industry has witnessed significant developments over the last 12-18 months, shaping the industry trends. Recent partnerships, such as those between pharmaceutical companies and cannabis providers, have accelerated research and development in the field. Notable mergers and acquisitions have also led to market consolidation, resulting in more efficient operations and expanded product offerings.

The Legal Marijuana for Medical Use industry trends are further influenced by product and technology launches, including innovative delivery systems and more potent strains. Regulatory changes, such as the easing of restrictions in certain countries, have also contributed to the growth of the industry. Moreover, a shift in consumer trends towards more natural and holistic treatments has increased demand for medical marijuana, driving funding rounds and expansions in the sector.

Analyst Overview

As the Lead Analyst, my expert view on the Legal Marijuana for Medical Use market is that it presents a highly attractive opportunity, driven by growing demand and increasing legalization globally. The competitive intensity is moderate, with key players focusing on innovation and expansion. The long-term outlook for the Legal Marijuana for Medical Use market outlook is promising, with expected growth in the next five years.

The innovation landscape is rapidly evolving, with new products and technologies being introduced. However, the demand–supply balance is a key concern, with supply chain disruptions and regulatory challenges affecting the market. Key risk factors include regulatory changes and public perception. Overall, the market offers significant opportunities for growth and investment, but it is crucial to navigate the complex landscape and mitigate potential risks.

11 items

1. Executive Summary

2. Legal Marijuana for Medical Use Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Legal Marijuana for Medical Use Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Legal Marijuana for Medical Use Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Cancer

6.1.2. Arthritis

6.1.3. Migraine

6.1.4. Epilepsy

6.1.5. Others

6.2. Global Legal Marijuana for Medical Use Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. THC-dominant

6.2.2. CBD-dominant

6.2.3. Balanced THC & CBD

6.3. Global Legal Marijuana for Medical Use Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Legal Marijuana for Medical Use Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Legal Marijuana for Medical Use Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Legal Marijuana for Medical Use Market Competition by Key Manufacturers

8.1. Global Legal Marijuana for Medical Use Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Legal Marijuana for Medical Use: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Canopy Growth Corporation

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. GW Pharmaceuticals, plc

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Aurora Cannabis, Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Aphria, Inc.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. MedReleaf Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Insys Therapeutics, Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. CanniMed Therapeutics, Inc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Cara Therapeutics, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. United Cannabis Corporation

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Medicine Man

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. mCig Inc

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Legal Marijuana for Medical Use Market

Figure 4: Global Legal Marijuana for Medical Use Market: Drivers

Figure 5: Global Legal Marijuana for Medical Use Market: Challenges

Figure 6: Global Legal Marijuana for Medical Use Market: Trends

Figure 7: Global Legal Marijuana for Medical Use Market: Opportunity

Figure 8: Global Legal Marijuana for Medical Use Market: Restraint

Figure 9: Global Legal Marijuana for Medical Use Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Legal Marijuana for Medical Use Market Value (USD Million) By Region

Figure 15: Global Legal Marijuana for Medical Use Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Legal Marijuana for Medical Use Market Value (USD Million) By Region

Figure 23: Global Legal Marijuana for Medical Use Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Legal Marijuana for Medical Use Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Legal Marijuana for Medical Use Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Legal Marijuana for Medical Use Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Legal Marijuana for Medical Use Market Value (USD Million) By Region

Table 10: Global Legal Marijuana for Medical Use Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Legal Marijuana for Medical Use Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Legal Marijuana for Medical Use Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Legal Marijuana for Medical Use Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Canopy Growth Corporation Basic Information And Sales Area

Table 31: Canopy Growth Corporation. Products Portfolio

Table 32: GW Pharmaceuticals, plc Basic Information And Sales Area

Table 33: GW Pharmaceuticals, plc. Products Portfolio

Table 34: Aurora Cannabis, Inc. Basic Information And Sales Area

Table 35: Aurora Cannabis, Inc.. Products Portfolio

Table 36: Aphria, Inc. Basic Information And Sales Area

Table 37: Aphria, Inc.. Products Portfolio

Table 38: MedReleaf Corporation Basic Information And Sales Area

Table 39: MedReleaf Corporation. Products Portfolio

Table 40: Insys Therapeutics, Inc. Basic Information And Sales Area

Table 41: Insys Therapeutics, Inc.. Products Portfolio

Table 42: CanniMed Therapeutics, Inc. Basic Information And Sales Area

Table 43: CanniMed Therapeutics, Inc.. Products Portfolio

Table 44: Cara Therapeutics, Inc. Basic Information And Sales Area

Table 45: Cara Therapeutics, Inc.. Products Portfolio

Table 46: United Cannabis Corporation Basic Information And Sales Area

Table 47: United Cannabis Corporation. Products Portfolio

Table 48: Medicine Man Basic Information And Sales Area

Table 49: Medicine Man. Products Portfolio

Table 50: mCig Inc Basic Information And Sales Area

Table 51: mCig Inc. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Legal Marijuana for Medical Use Market Value (USD Million) By Region

Table 57: Global Legal Marijuana for Medical Use Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Legal Marijuana for Medical Use Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	24.00 billion
Revenue forecast in 2033	73.93 billion
Growth rate	CAGR of 15.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Canopy Growth Corporation; GW Pharmaceuticals, plc; Aurora Cannabis, Inc.; Aphria, Inc.; MedReleaf Corporation; Insys Therapeutics, Inc.; CanniMed Therapeutics, Inc.; Cara Therapeutics, Inc.; United Cannabis Corporation; Medicine Man; mCig Inc
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options